Value Adjusted for Debt and Cash: zurabio.com (ZURA)
The price history of Zura Bio Limited (ZURA) reflects the valuation dynamics of a business whose strategy is based on developing antibodies against inflammatory pathologies and expanding its drug portfolio to minimize risks. The current figure is 231.37. Zura Bio Limited (ZURA) possesses sufficient capital for its own research and plans to enter into future licensing agreements with major industry players. Its monopoly status in niche segments is secured by the exclusive ownership of unique molecules.
Zura Bio Limited (ZURA) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- business debt structure and liquidity details:
- business earnings and investment ratios data:
Analysis of all company metrics:Zura Bio Ltd
Zura Bio Limited (ZURA) is intensively developing bispecific antibodies for the therapy of severe autoimmune pathologies, leveraging the patent protection of its molecules. By analyzing the enterprise value, an investor can determine the actual buyout cost of the company through the sum of market capitalization and net debt, which allows for an objective assessment of the value of intellectual assets and the risks of overpaying for R&D potential.
Competitors of Zura Bio Limited (ZURA)
Enterprise Value argenx N.V. ARGX|BNTX - Total Company Value|Value Adjusted for Debt and Cash ABVX (Abivax Pharma)|ADMA: Enterprise Value|protagonist-inc.com (PTGX) - Enterprise Value|Total Company Value Immunovant|Kiniksa Pharmaceuticals, Ltd. - Full Business Value|Enterprise Value GRFS|ADPT (Adaptive Biotechnologies Inc.) - Value Adjusted for Debt and Cash|Enterprise Value CLDX (Celldex Therapeutics)|Enterprise Value auriniapharma.com AUPH|BCRX - Total Company Value|Value Adjusted for Debt and Cash VERA (Vera Therapeutics Inc)|Dianthus Pharma (DNTH) - Total Company Value|Real Price to Acquire Entire Company Pharvaris Pharma|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com|Real Price to Acquire Entire Company PGEN (Precigen)|PHAR (Pharming Group NV) - Value Adjusted for Debt and Cash|Enterprise Value NKTR (Nektar)|Company Buyout Price Upstream Pharma (UPB)|ZBIO - Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|Gossamer Bio (GOSS) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|Real Price to Acquire Entire Company SEPN|Enterprise Value Pieris Corp|Total Company Value Savara Inc. (SVRA)|rigel.com - Business Value|Enterprise Value ANAB (AnaptysBio)|Astria Therapeutics Inc (ATXS) - Total Enterprise Value|ENGN: Real Price to Acquire Entire Company|Full Business Value RAPT|JBIO (aerovatetx.com) - Real Price to Acquire Entire Company|aclaristx.com (ACRS) - Enterprise Value|Total Company Value Kyverna Therapeutics, Inc.|TLSA: Value Adjusted for Debt and Cash|Enterprise Value CABA|Enterprise Value Ventyx Biosciences, Inc (VTYX)|Theratechnologies Inc. - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash AVTX|Eledon Pharmaceuticals, Inc. - Enterprise Value|AGEN: Total Company Value|CLYM: Enterprise Value|ATYR - Company Buyout Price|Total Company Value Adagene Inc|Total Enterprise Value Ikena Oncology, Inc. IMA|Real Price to Acquire Entire Company STTK (Shattuck Labs, Inc.)|EQ (equilliumbio.com) - Value Adjusted for Debt and Cash|Total Company Value Connect Biopharma Holdings Limited CNTB|Immunic Therapeutics - Total Company Value|Atara Biotherapeutics Inc - Enterprise Value|Company Buyout Price InflaRx N.V. IFRX|X4 Pharmaceuticals, Inc. (XFOR) - Total Company Value|Real Price to Acquire Entire Company Adicet Bio, Inc.|CELU (Celularity Inc) - Enterprise Value|INmune Bio Corporation (INMB) - Company Buyout Price|Real Price to Acquire Entire Company BRNS (Barinthus Biotherapeutics)|Aggregate Business Value KZR|Enterprise Value SABS (SAB Biotherapeutics, Inc.)|Akari Therapeutics PLC (AKTX) - Total Enterprise Value|Enlivex Therapeutics, Ltd. - Enterprise Value|QTTB (Q32 Bio Inc.) - Business Value|GOVX (GeoVax Labs, Inc.) - Real Price to Acquire Entire Company|Full Business Value EDSA (edesabiotech.com)|Real Price to Acquire Entire Company IBIO|Enterprise Value Carisma Tx|Total Company Value XTL Biopharmaceuticals, Ltd. (XTLB)|BOLT (boltbio.com) - Value Adjusted for Debt and Cash|Enterprise Value HCWB (HCW Biologics)|Enterprise Value Aptevo Therapeutics, Inc. APVO|AIM - Total Company Value|Full Business Value ADTX|GRI: Enterprise Value|XORTX Corp - Value Adjusted for Debt and Cash|HIND (Vyome Holdings Inc) - Enterprise Value|Enterprise Value revbiosciences.com|Total Company Value Indaptus Therapeutics, Inc. (INDP)|SCNI (Scinai Immunotherapeutics Ltd) - Value Adjusted for Debt and Cash|Total Company Value CalciMedica CALI|AFMD - Real Price to Acquire Entire Company|Allakos Therapeutics - Enterprise Value|HOOK - Enterprise Value|IGMS (igmbio.com) - Real Price to Acquire Entire Company|iTeos Therapeutics Inc - Value Adjusted for Debt and Cash|OCEA (Ocean Bio) - Enterprise Value|TC BioPharm Ltd (TCBP) - Company Buyout Price|Total Company Value Third Harmonic Bio (THRD)